Formulation of a mixture of Free-B-Ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments
The present invention provides a novel method for preventing and treating memory and cognitive impairment resulting from oxidative stress, inflammation and the process of aging, as well as, neurodegenerative conditions. The method is comprised of administering a composition comprising a mixture of Free-B-Ring flavonoids and flavans synthesized and/or isolated from a single plant or multiple plants to a host in need thereof. The present also includes a novel method for simultaneously inhibiting expression of pro-inflammatory cytokines, preventing ROS generation and augmenting anti-oxidant defenses. The activity of this composition is conducive to ultimately preserving cognitive function and providing a level of neuroprotection.
1. A method for treating cyclooxygenase and lipoxygenase mediated inflammatory diseases and conditions related to memory and cognitive function, said method comprising administering to a host in need thereof an effective amount of a composition comprised of a mixture of an extract derived from Scutellaria enriched for Free-B-Ring flavanoids containing baicalin and an extract derived from Acacia enriched for flavans containing catechin or epicatechin wherein said cyclooxygenase and lipoxygenase mediated inflammatory diseases and conditions are selected from the group consisting of neurodegenerative disorders, stroke, dementia, Alzheimer's disease, Parkinson's disease, Huntington's disease, and Amyotrophic Lateral Sclerosis.
2. The method of claim 1 wherein the ratio of Free-B-Ring flavonoids to flavans in said composition is selected from the range of 99:1 Free-B-Ring flavonoids:flavans to 1:99 of Free-B-Ring flavonoids:flavans.
3. The method of claim 2 wherein the ratio of Free-B-Ring flavonoids:flavans in the composition of matter is about 80:20.
4. The method of claim 1 wherein said Free-B-Ring flavonoids and said flavans are isolated from a plant part selected from the group consisting of stems, stem barks, trunks, trunk barks, twigs, tubers, roots, root barks, young shoots, seeds, rhizomes, flowers and other reproductive organs, leaves and other aerial parts.
5. The method claim 1 wherein said flavans are isolated from a plant species selected from the group consisting of the Acacia caechu, Acacia concinna, Acacia farnesiana, Acacia Senegal, Acacia speciosa, Acacia arabica, Acacia caesia, Acacia pennata, Acacia sinuate, Acacia Mearnsii, Acacia picnantha, Acacia dealbata, Acacia auriculiformis, Acacia holosercia, and Acacia mangium.
6. The method of claim 1 wherein the composition is administered in a dosage selected from 0.001 to 200 mg/kg of body weight of said host.
7. The method of claim 1 wherein the administration is selected from the group consisting of oral, topical, suppository, intravenous, and intradermic, intragaster, intramusclar, intraperitoneal and intravenous administration.
8. The method of claim 1 wherein the composition is further comprised of a conventional excipient that is pharmaceutically, dermatologically and cosmetically suitable for topical application.